Search is Powered by Google
Cancer / Oncology News

ASCO-NCI Event On Cancer In The Developing World Now Available Online

Main Category: Cancer / Oncology
Also Included In: IT / Internet / E-mail
Article Date: 07 Jan 2008 - 4:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

The joint American Society of Clinical Oncology (ASCO) and National Cancer Institute (NCI) Science Writers' Seminar on Cancer in the Developing World is now available at http://www.asco.org/presscenter and a new issue of BenchMarks on the Global Burden of Cancer will be posted shortly here.

Cancer in the Developing World, featured internationally recognized experts providing an in-depth, informative look at many issues surrounding cancer in less developed countries including: geographic incidence, survival and mortality trends; the state of cancer prevention, screening and treatment in less developed countries; perspectives on cancer care from Africa, Asia and India; major international cancer initiatives such as prevention, tobacco control and palliative care; and ASCO and NCI initiatives to address the global cancer burden. Presentations by the following experts are featured:

- Nancy E. Davidson, M.D.; ASCO President, Sidney Kimmel Comprehensive Cancer Center
- Lynn Ries, M.S.; SEER Cancer Registry, NCI
- Tony Mok, M.D.; The Chinese University of Hong Kong-Hong Kong, China
- Ketayun Dinshaw, M.D.; Tata Memorial Hospital-Mumbai (formerly known as Bombay), India
- Clement Adebayo Adebamowo, M.D.; University College Hospital-Lagos, Nigeria
- Joe Harford, Ph.D.; Director; Office of International Affairs, NCI
- Deirdre Lawrence, Ph.D.; Tobacco Control Research Branch, NCI

The audio track, slide presentations, bios and fact sheets from this Science Writers' Seminar event are also available through ASCO's online press center. Logon to http://www.asco.org/presscenter and click on the Meet the Experts link.

Past ASCO media events are also available online and cover such topics as:

- Personalized Cancer Medicine - Translating Breakthroughs in Biology into Better Treatment for Patients (December 2006)
- Targeted Therapies - The Next Generation (December 2005)
- Cancer Survivorship - Increasing Survival, Improving Lives (December 2004)
- The Virus Cancer Link (December 2003)
- New Strategies in Cancer Prevention and Screening (December 2002)

The American Society of Clinical Oncology (ASCO) is the world's leading professional organization representing physicians who care for people with cancer. With more than 25,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. For ASCO information and resources, visit http://www.asco.org/presscenter. Patient-oriented cancer information is available at http://www.plwc.org.

For more information about cancer, please visit the NCI Web site at http://www.cancer.gov.





Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Shocking Pictures To Appear On Cigarette Packets In UK On 1st October
27 Sep 2008
The UK's ten million Smokers may see pictures of rotting teeth, throat cancer, and indications of male impotence (erectile dysfunction) on cigarette packets they buy at the beginning of October...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...